Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.35
0.121.30%
At close: -
$9.35
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Theravance Biopharma Stock Price, Quotes and Forecasts
TBPHNASDAQ
Theravance Biopharma (TBPH) Forecast
NewsEarningsTheravance Biopharma (TBPH) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Theravance Biopharma Stock Price, Quotes and Forecasts | NASDAQ:TBPH | Benzinga
Explore Theravance Biopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TBPH.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Theravance Biopharma (TBPH) stock?
You can purchase shares of Theravance Biopharma (NASDAQ:TBPH) through any online brokerage.
Who are Theravance Biopharma (TBPH) competitors?
Other companies in Theravance Biopharma’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), Xeris Biopharma Holdings (NASDAQ:XERS) and Phibro Animal Health (NASDAQ:PAHC).
What is the forecast, or price target, for Theravance Biopharma (TBPH) stock?
Theravance Biopharma has a consensus price target of $13.17.
What is the current price for Theravance Biopharma (TBPH)?
The stock price for Theravance Biopharma (NASDAQ: TBPH) is $9.35 last updated March 17, 2025 at 4:00 PM EDT.
Does Theravance Biopharma (TBPH) pay a dividend?
There are no upcoming dividends for Theravance Biopharma.
When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?
Theravance Biopharma’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Theravance Biopharma (TBPH) going to split?
There is no upcoming split for Theravance Biopharma.
What sector and industry does Theravance Biopharma (TBPH) operate in?
Theravance Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.